Corsmed Secures €3.3 Million to Revolutionize MRI Technology

Corsmed is a Stockholm-based startup that specializes in advanced MRI simulation technology. The startup has just closed a successful funding round of €3.3 million. The investment will accelerate the commercialization of its innovative software, making MRI scans faster, more affordable, and more accessible worldwide.

Corsmed was founded in 2016 by the CEO Erik Jacobsson and CTO Dr. Christos Xanthis with the development of a high-performance MRI simulation platform, dedicated for education, training, as well as research. Corsmed’s mission is to democratize MRI technology – providing faster, cheaper and better preventive health solutions for all, everywhere.

Innovation: AI Accelerated MRI Software

Corsmed’s software uses AI to cut the time of MRI scans drastically. While it takes a traditional MRI up to an hour, the technology of Corsmed will deliver multiple high-resolution full 3D images of the brain within three minutes, ten times faster than the current clinical norm. This innovation deals with crucial bottlenecks in diagnostic imaging and is capable of transforming healthcare delivery across the world.

Funding and Future Plans

The €3.3 million investment will go mainly into the commercialization of Corsmed’s technology, ensuring that it will be compliant with U.S. FDA and HIPAA standards. It will also increase distribution efforts globally. Notable investors in this funding round include Luminar Ventures and Big Pi Ventures.

To democratize MRI scans is a cornerstone in the creation of preventive healthcare. We estimate that Corsmed can save tens of thousands of lives per day by enabling the detection of life-threatening conditions 10x cheaper than today.” Magnus Bergman, co-founding Partner at Luminar Ventures, said.

Nick Kalliagkopoulos, Partner at Big Pi Ventures, echoed this: “Corsmed has the potential to fundamentally change healthcare worldwide. The team has developed a technology that can truly unlock preventative and personalized health.” EU STARTUPS

With this technology, Corsmed’s product is promising to take away the burden from the healthcare system, especially in regions that have limited access to advanced imaging equipment. More rapid scans translate to more throughput for patients, reduced waiting times, and the detection of life-threatening conditions much earlier.

It is also through this shift toward quantitative imaging that it enables accurate, objective data for monitoring health changes over time and hence enables personalized treatment plans and improved patient outcomes.

Educational and Training Applications

Apart from clinical applications, Corsmed’s MRI simulator is an excellent resource for medical education and training. It allows users to practice and improve their MRI scanning skills in a safe virtual environment that closely replicates real-life scenarios without the associated costs and risks. This feature is especially useful for universities, colleges, clinics, and hospitals that wish to provide hands-on MRI training at scale.

Global Reach and Future Prospects

With this new funding, Corsmed is ready to open its global footprint and get its revolutionary MRI technology spread out to healthcare providers as well as educational institutions everywhere in the world.

The company demonstrates a commitment to compliance standards in international markets, be it the U.S. FDA or HIPAA standards, to ensure safe and effective solution delivery across diverse markets.

As the healthcare industry continues to embrace digital transformation, Corsmed’s AI-accelerated MRI software stands at the forefront of innovations poised to enhance diagnostic capabilities, improve patient care, and reduce healthcare costs on a global scale.